Matthew K Fust - Net Worth and Insider Trading
Matthew K Fust Net Worth
The estimated net worth of Matthew K Fust is at least $2 Million dollars as of 2024-05-25. Matthew K Fust is the Director of Crinetics Pharmaceuticals Inc and owns about 18,536 shares of Crinetics Pharmaceuticals Inc (CRNX) stock worth over $879,904. Matthew K Fust is the Director of Ultragenyx Pharmaceutical Inc and owns about 14,860 shares of Ultragenyx Pharmaceutical Inc (RARE) stock worth over $599,452. Matthew K Fust is also the Director of Dermira Inc and owns about 5,051 shares of Dermira Inc (DERM) stock worth over $94,706. Besides these, Matthew K Fust also holds Atara Biotherapeutics Inc (ATRA) , Macrogenics Inc (MGNX) . Details can be seen in Matthew K Fust's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Matthew K Fust has not made any transactions after 2024-03-20 and currently still holds the listed stock(s).
Transaction Summary of Matthew K Fust
Matthew K Fust Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew K Fust owns 7 companies in total, including Ultragenyx Pharmaceutical Inc (RARE) , Crinetics Pharmaceuticals Inc (CRNX) , and Atara Biotherapeutics Inc (ATRA) among others .
Click here to see the complete history of Matthew K Fust’s form 4 insider trades.
Insider Ownership Summary of Matthew K Fust
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RARE | Ultragenyx Pharmaceutical Inc | 2024-03-07 | director |
CRNX | Crinetics Pharmaceuticals Inc | 2024-03-20 | director |
ATRA | Atara Biotherapeutics Inc | 2021-11-04 | director |
2020-02-20 | director | ||
2019-02-06 | director | ||
2007-05-31 | Senior Vice President & CFO | ||
2023-09-14 | director |
Matthew K Fust Latest Holdings Summary
Matthew K Fust currently owns a total of 5 stocks. Among these stocks, Matthew K Fust owns 18,536 shares of Crinetics Pharmaceuticals Inc (CRNX) as of March 20, 2024, with a value of $879,904 and a weighting of 55.13%. Matthew K Fust owns 14,860 shares of Ultragenyx Pharmaceutical Inc (RARE) as of March 7, 2024, with a value of $599,452 and a weighting of 37.56%. Matthew K Fust also owns 5,051 shares of Dermira Inc (DERM) as of December 24, 2019, with a value of $94,706 and a weighting of 5.93%. The other 2 stocks Atara Biotherapeutics Inc (ATRA) , Macrogenics Inc (MGNX) have a combined weighting of 1.37% among all his current holdings.
Latest Holdings of Matthew K Fust
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CRNX | Crinetics Pharmaceuticals Inc | 2024-03-20 | 18,536 | 47.47 | 879,904 |
RARE | Ultragenyx Pharmaceutical Inc | 2024-03-07 | 14,860 | 40.34 | 599,452 |
DERM | Dermira Inc | 2019-12-24 | 5,051 | 18.75 | 94,706 |
ATRA | Atara Biotherapeutics Inc | 2021-11-04 | 31,500 | 0.62 | 19,656 |
MGNX | Macrogenics Inc | 2019-02-06 | 500 | 4.55 | 2,275 |
Holding Weightings of Matthew K Fust
Matthew K Fust Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew K Fust has made a total of 8 transactions in Crinetics Pharmaceuticals Inc (CRNX) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Crinetics Pharmaceuticals Inc is the sale of 60,000 shares on March 20, 2024, which brought Matthew K Fust around $3 Million.
According to the SEC Form 4 filings, Matthew K Fust has made a total of 5 transactions in Ultragenyx Pharmaceutical Inc (RARE) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Ultragenyx Pharmaceutical Inc is the sale of 12,195 shares on March 7, 2024, which brought Matthew K Fust around $620,482.
According to the SEC Form 4 filings, Matthew K Fust has made a total of 3 transactions in Dermira Inc (DERM) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Dermira Inc is the sale of 3,000 shares on December 24, 2019, which brought Matthew K Fust around $45,000.
More details on Matthew K Fust's insider transactions can be found in the Insider Trading History of Matthew K Fust table.Insider Trading History of Matthew K Fust
- 1
Matthew K Fust Trading Performance
Matthew K Fust Ownership Network
Ownership Network List of Matthew K Fust
Ownership Network Relation of Matthew K Fust
Matthew K Fust Owned Company Details
What does Ultragenyx Pharmaceutical Inc do?
Who are the key executives at Ultragenyx Pharmaceutical Inc?
Matthew K Fust is the director of Ultragenyx Pharmaceutical Inc. Other key executives at Ultragenyx Pharmaceutical Inc include EVP and Chief Medical Officer Eric Crombez , CBO & Senior Vice President Thomas Richard Kassberg , and EVP and General Counsel Karah Herdman Parschauer .
Ultragenyx Pharmaceutical Inc (RARE) Insider Trades Summary
Over the past 18 months, Matthew K Fust made 1 insider transaction in Ultragenyx Pharmaceutical Inc (RARE) with a net sale of 12,195. Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 5,605 shares made by Theodore Alan Huizenga , a net sale of 127,435 shares made by Emil D Kakkis , and a net sale of 54,366 shares made by Thomas Richard Kassberg .
In summary, during the past 3 months, insiders sold 39,487 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 39,487 shares. During the past 18 months, 243,647 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 243,647 shares.
Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ultragenyx Pharmaceutical Inc Insider Transactions
Matthew K Fust Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew K Fust. You might contact Matthew K Fust via mailing address: C/o Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato Ca 94949.